CODY SKAINS: Open Payments
NPI 1144912932 · FORNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,894 in 92 payments from 23 companies in 2025. Trend: 2023 $402 · 2024 $1,264 · 2025 $1,894
Food & beverage: $1,894
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $409 |
| ABBVIE INC. | 12 | $155 |
| Corcept Therapeutics | 3 | $153 |
| Antares Pharma, Inc. | 9 | $149 |
| PFIZER INC. | 7 | $147 |
| Phathom Pharmaceuticals, Inc. | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Lilly USA, LLC | 4 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
| GlaxoSmithKline, LLC. | 4 | $67 |
Products named: Ozempic, Korlym, XYOSTED, VOQUEZNA, REXULTI, Wegovy, XIFAXAN, QULIPTA.
Industry payments across TX — which companies pay providers there.
